• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

January 20, 2025

Study Reports Dietary Recommendation for Managing GLP-1-Related Gastrointestinal Adverse Events

Author(s):

Ashley Gallagher, Editor

Key Takeaways

  • GLP-1 receptor agonists facilitate weight loss in non-diabetic adults, with gastrointestinal adverse events being the most common safety concern.
  • Dietary recommendations aim to mitigate gastrointestinal symptoms, focusing on food consistency, meal composition, and lifestyle factors.
  • The adapted Harvard Healthy Plate emphasizes moderate complex carbohydrates, low-fat proteins, and low-fiber vegetables for managing gastrointestinal symptoms.
  • Patients are advised to consume small, frequent meals, avoid complex dishes, spicy foods, and alcohol, and maintain hydration.
SHOW MORE

Recommendations help influence the rate of gastric emptying, improve compliance, and prevent interruption of weight loss for patients.

In a study published in Diabetes, Metabolic Syndrome, and Obesity, investigators compiled dietary recommendations that help influence the rate of gastric emptying, improve compliance, and prevent interruption of weight loss for patients who are being treated with glucagon-like peptide-1 (GLP-1) receptor agonists.1

Diet, Nutrition, GLP-1, Weight Loss | Image Credit: aamulya | stock.adobe.com

Diet, Nutrition, GLP-1, Weight Loss | Image Credit: aamulya | stock.adobe.com

According to the World Health Organization (WHO), approximately 43% of adults 18 years and older were living with overweight in 2022 worldwide, and 16% were living with obesity. WHO defines overweight as a body mass index (BMI) of greater than or equal to 25 and obesity as a BMI greater than or equal to 30. Obesity has been established as a multifactorial disease, including obesogenic environments, psycho-social factors, and genetic variants.2

Recently, a new analysis published in Annals of Internal Medicine shows GLP-1 receptor agonists and co-agonists facilitate weight loss for adults with overweight or obesity and without diabetes. The safety concerns reported by investigators were generally gastrointestinal, which supports previous safety findings for GLP-1 medication.3

The analysis showed that tirzepatide showed weight loss of up to 17.8%, semaglutide showed up to 13.9%, and liraglutide showed up to 5.8%. Adverse events (AEs) were frequent, with the majority being gastrointestinal-related, such as nausea, vomiting, diarrhea, and constipation. Investigators also found that AEs requiring discontinuation and serious AEs were rare.3

In the current study, investigators set out to compose dietary advice to help mitigate gastrointestinal symptoms, including food consistency, viscosity, meal composition, and lifestyle factors. The study authors reported that studies were included if they focused on individual treated with GLP-1s or the physiology of gastric emptying and were published within the last 20 years. After the initial search, 2 authors assessed the titles and abstracts of the relevant studies, then reviewed the full text. Any disagreements were solved by a third author.1

According to the study authors, the management of gastrointestinal AEs is essential for treatment adherence, and prescribers will also adjust the dose for the management of the AEs. However, the authors note that AEs often occur in patients with inadequate diet, and so far, there is no specific guidance on caloric restriction and type of foods that can help or harm GLP-1 treatment.1

Investigators established an adapted version of the Harvard Healthy Plate, which includes guidance on cereals, protein, fats and vegetables, as tools to manage gastrointestinal symptoms. The tool created does not specify quantities as the authors believe that the guidance should be tailored specifically to the individual’s needs and goals. Further, since the AEs often occur in the evening, the findings offer advice for dinner.1

The findings suggest that complex carbohydrates, including pasta, bread, and crackers, could help to manage the impact of fiber and glucose on gastric emptying, and the food should be moderate to support digestion. Patients should avoid whole grain products and foods that were high in simple sugars. Protein such as red meats and processed cold cuts can delay gastric emptying, but low-fat protein sources such as white meats and blue fish are recommended. Moderate temperature, fresh cheese is recommended, but mature cheeses, which contain higher fat content, should be avoided. Legumes should be avoided due to their high fiber content and are best consumed during lunch.1

For fats, investigators recommend moderation as fats are essential for overall health, but extra virgin olive oil is preferred because of health benefits, including anti-inflammatory and cardioprotective benefits. Fiber can slow gastric emptying, so low-fiber vegetables are recommended as well as an appropriate portion size. The authors suggest portion sizes should be kept to maintain digestive comfort but should be personalized for each patient.1

Additionally, dietary recommendations include consuming small, frequent meals, using simple cooking methods, avoiding complex dishes, spicy foods, and alcohol, staying well-hydrated, choosing fruits as a snack, and avoiding lying down, and engaging vigorous activity post-meal.1

REFERENCES
1. Gentinetta S, Sottotetti F, Manuelli M, Cena H. Dietary Recommendations for the Management of Gastrointestinal Symptoms in Patients Treated with GLP-1 Receptor Agonist. Diabetes Metab Syndr Obes. 2024;17:4817-4824. Published 2024 Dec 19. doi:10.2147/DMSO.S494919
2. CDC. Obesity and overweight. March 1, 2024. Accessed January 9, 2025. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
3. Moiz A, Filion KB, Toutounchi H, et al. Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes: A Systematic Review of Randomized Controlled Trials. Ann Intern Med. Published online January 7, 2025. doi:10.7326/ANNALS-24-01590
Related Videos
Happy elderly patient with medical health checkup with cardiologist or geriatric doctor. Senior old aging woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Related Content
Advertisement
Wegovy injection pen | Image Credit: © Patrick Bay Damsted - stock.adobe.com
May 7th 2025

GLP-1 Drugs Show Promise in Lowering Health Care Costs, Report Says

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
AI at the Counter: How Artificial Intelligence Is Shaping the Future of Pharmacy Practice
May 7th 2025

AI at the Counter: How Artificial Intelligence Is Shaping the Future of Pharmacy Practice

Alaa Abdul Ghani, PharmD
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Long Covid patient with post viral fatigue syndrome pushing a metaphoric Coronavirus up a mountain in Sisyphus concept vector
May 6th 2025

Constraint-Induced Cognitive Therapy Found to Improve Multiple Long COVID Symptoms

Luke Halpern, Assistant Editor
Rite Aid Intends to File Second Bankruptcy, Raising Questions About Its Future
May 5th 2025

Rite Aid Intends to File Second Bankruptcy, Raising Questions About Its Future

Aislinn Antrim, Managing Editor
Related Content
Advertisement
Wegovy injection pen | Image Credit: © Patrick Bay Damsted - stock.adobe.com
May 7th 2025

GLP-1 Drugs Show Promise in Lowering Health Care Costs, Report Says

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
AI at the Counter: How Artificial Intelligence Is Shaping the Future of Pharmacy Practice
May 7th 2025

AI at the Counter: How Artificial Intelligence Is Shaping the Future of Pharmacy Practice

Alaa Abdul Ghani, PharmD
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Long Covid patient with post viral fatigue syndrome pushing a metaphoric Coronavirus up a mountain in Sisyphus concept vector
May 6th 2025

Constraint-Induced Cognitive Therapy Found to Improve Multiple Long COVID Symptoms

Luke Halpern, Assistant Editor
Rite Aid Intends to File Second Bankruptcy, Raising Questions About Its Future
May 5th 2025

Rite Aid Intends to File Second Bankruptcy, Raising Questions About Its Future

Aislinn Antrim, Managing Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.